Study #2016-1035
Optimizing Preventative Adjuvant Linac-based Radiation: the OPAL Trial A Phase II/III Study of Hypofractionated Partial Breast Irradiation in Women with Early Stage Breast Cancer
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This phase II trial studies how well hypofractionated partial breast irradiation works in treating patients with early stage breast cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells and have fewer side effects. Treating only the part of the breast where the cancer started may lead to fewer side effects than standard treatment.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Ductal Breast Carcinoma In Situ;Early-Stage Breast Carcinoma;Invasive Breast Carcinoma;Stage 0 Breast Cancer AJCC v6 and v7;Stage I Breast Cancer AJCC v7;Stage IA Breast Cancer AJCC v7;Stage IB Breast Cancer AJCC v7;Stage II Breast Cancer AJCC v6 and v7;Stage IIA Breast Cancer AJCC v6 and v7;Stage IIB Breast Cancer AJCC v6 and v7
Study phase:
Phase II/III
Physician name:
Benjamin Smith
Department:
Radiation Oncology
For general questions about clinical trials:
1-877-632-6789
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.